Callos Andrew sold CYTK
February 5, 2026 · Form 4 insider transaction
Callos Andrew sold 15,000 shares of Cytokinetics, Incorporated at $61.93 per share, a transaction worth $929.0K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
15,000
Price
$61.93
Total value
$929.0K
InsiderCallos Andrew
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 5, 2026
Filing dateFebruary 5, 2026
Shares owned after50,440
OwnershipDirect
10b5-1 planNo
AmendedNo